Home Compare SAN.PA
Peer Analysis

Sanofi — Peer Companies & Stock Comparisons

Sanofi's functional peer companies ranked by peer score — growth, valuation, profitability and stability compared.

Compare SAN.PA with peers
Comparison SAN.PA peer score
Sanofi vs Regeneron Pharmaceuticals, Inc.
70 Compare →
Sanofi vs Danaher Corporation
49 Compare →
Sanofi vs Medtronic plc
57 Compare →
Sanofi vs Qiagen N.V.
46 Compare →
Sanofi vs Biogen Inc.
44 Compare →
Sanofi vs Lamar Advertising Company
39 Compare →
Sanofi vs Zimmer Biomet Holdings, Inc.
55 Compare →
Sanofi vs Thomson Reuters Corporation
53 Compare →
Sanofi vs Amgen Inc.
68 Compare →
Sanofi vs Diageo plc
47 Compare →

Full SAN.PA analysis in AssetNext

View the complete Sanofi report including all peer dimensions.

Open in AssetNext →

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.